The Drugs Controller General

Covid-19: DCGI gives nod to Serum Institute to hold Phase II, III COVID vaccine trials

The Drugs Controller General of India (DCGI) gave approval to Serum Institute of India, Pune to conduct Phase II+III clinical trials of Oxford Univers...

Monday, August 3, 2020 7:45 PM